Sativex® commercialisation approval in Italy

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Sativex® commercialisation approval in Italy

Post by MSUK » Tue May 07, 2013 1:08 am

GW Pharmaceuticals plc has announced that it has received commercialisation approval for its prescription medicine Sativex® in Italy. A full marketing authorization has been granted by the authorities in Italy for the treatment of moderate to severe spasticity in Multiple Sclerosis (MS) patients who have not responded adequately to other anti-spasticity medications....... Read More - http://www.ms-uk.org/index.cfm/sativex
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post